These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 24217265)

  • 1. Anticoagulation: 'putting new evidence into clinical practice'.
    Hardy G
    Cardiovasc J Afr; 2013 Jul; 24(6):243-4. PubMed ID: 24217265
    [No Abstract]   [Full Text] [Related]  

  • 2. The new era of anticoagulation.
    Skeik N; Rumery KK; Rodriguez GT
    Ann Vasc Surg; 2014 Feb; 28(2):503-14. PubMed ID: 24412298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Old and new oral anticoagulants for venous thromboembolism and atrial fibrillation: a review of the literature.
    Becattini C; Vedovati MC; Agnelli G
    Thromb Res; 2012 Mar; 129(3):392-400. PubMed ID: 22264937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Edoxaban in venous thromboembolism and stroke prevention: an appraisal.
    Proietti M; Lip GY
    Vasc Health Risk Manag; 2016; 12():45-51. PubMed ID: 27013883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Lesions.
    Di Biase L
    J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26892528
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of the direct oral anticoagulants in obese patients: guidance from the SSC of the ISTH.
    Martin K; Beyer-Westendorf J; Davidson BL; Huisman MV; Sandset PM; Moll S
    J Thromb Haemost; 2016 Jun; 14(6):1308-13. PubMed ID: 27299806
    [No Abstract]   [Full Text] [Related]  

  • 7. Rivaroxaban: an oral factor Xa inhibitor.
    Thomas TF; Ganetsky V; Spinler SA
    Clin Ther; 2013 Jan; 35(1):4-27. PubMed ID: 23328267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anticoagulation in atrial fibrillation. Strategies in special situations].
    Volkmann H; Walter M; Walter C; Vetter S
    Clin Res Cardiol Suppl; 2011 May; 6():58-65. PubMed ID: 22528179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct oral anticoagulants: unique properties and practical approaches to management.
    Barnes GD; Kurtz B
    Heart; 2016 Oct; 102(20):1620-6. PubMed ID: 27402803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticoagulation risk assessment for patients with non-valvular atrial fibrillation and venous thromboembolism: A clinical review.
    Pallazola VA; Kapoor RK; Kapoor K; McEvoy JW; Blumenthal RS; Gluckman TJ
    Vasc Med; 2019 Apr; 24(2):141-152. PubMed ID: 30755150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New oral anticoagulants in development.
    Weitz JI
    Thromb Haemost; 2010 Jan; 103(1):62-70. PubMed ID: 20062934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulation for atrial fibrillation: state of the art and recommendations for a quickly moving target.
    Nattel S; Cairns J; Healey JS; Talajic M
    Can J Cardiol; 2013 Jul; 29(7 Suppl):S1-3. PubMed ID: 23790593
    [No Abstract]   [Full Text] [Related]  

  • 13. Updated guidelines on outpatient anticoagulation.
    Wigle P; Hein B; Bloomfield HE; Tubb M; Doherty M
    Am Fam Physician; 2013 Apr; 87(8):556-66. PubMed ID: 23668445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. South Africa's poor warfarin control raises questions of benefit above other anticoagulant therapies in atrial fibrillation.
    Aalbers J
    Cardiovasc J Afr; 2011; 22(4):220. PubMed ID: 21881695
    [No Abstract]   [Full Text] [Related]  

  • 15. Novel oral anticoagulants for stroke prevention in atrial fibrillation: results of the European Heart Rhythm Association survey.
    Lip GY; Bongiorni MG; Dobreanu D; Lewalter T; Hastrup Svendsen J; Blomström-Lundqvist C;
    Europace; 2013 Oct; 15(10):1526-32. PubMed ID: 24072770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New avenues for anticoagulation in atrial fibrillation.
    Mantha S; Cabral K; Ansell J
    Clin Pharmacol Ther; 2013 Jan; 93(1):68-77. PubMed ID: 23212107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MY APPROACH to the practical management of anticoagulation in patients with atrial fibrillation.
    Flaker G
    Trends Cardiovasc Med; 2016 Apr; 26(3):292. PubMed ID: 26874917
    [No Abstract]   [Full Text] [Related]  

  • 18. New anticoagulants for venous thromboembolism and atrial fibrillation: what the future holds.
    Dimitropoulos G; Rahim SMZ; Moss AS; Lip GYH
    Expert Opin Investig Drugs; 2018 Jan; 27(1):71-86. PubMed ID: 29224364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dabigatran etexilate for stroke prevention in patients with atrial fibrillation: resolving uncertainties in routine practice.
    Huisman MV; Lip GY; Diener HC; Brueckmann M; van Ryn J; Clemens A
    Thromb Haemost; 2012 May; 107(5):838-47. PubMed ID: 22318514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical management of rivaroxaban-treated patients.
    Palareti G; Ageno W; Ferrari A; Filippi A; Imberti D; Pengo V; Rubboli A; Toni D
    Expert Opin Pharmacother; 2013 Apr; 14(5):655-67. PubMed ID: 23414291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.